How a Heart Attack Is Treated

In This Article
Table of Contents

Treatment of an acute heart attack (myocardial infarction, MI) must be early and aggressive. Medical therapy is used to stabilize the cardiovascular system and prevent or at least mitigate long-term complications. This may include angioplasty and the use of thrombolytics or other priority medications for a heart attack.

Heart attacks need to be urgently treated because the blockage of one of the coronary arteries that supplies blood to the heart causes an area of muscle to begin to die—and the longer blood flow is hindered, the more damage that occurs.

Immediate Priorities

The first few hours after a heart attack are critical. Getting medical help as rapidly as possible is essential to preventing cardiac arrest, preserving heart muscle, and preventing further blood clots from forming. In fact, national guidelines recommend that the affected coronary artery be opened within 90 minutes for best outcome.

If you arrive at the hospital with a possible heart attack, medical personnel will immediately check your vital signs (pulse and blood pressure) and prepare to deal with any apparent life-threatening conditions, such as ventricular fibrillation.

Treatment is started once a heart attack is suspected. This can include:

  • Aspirin given to prevent further blood clotting
  • Oxygen therapy
  • Nitroglycerine to improve blood flow
  • Chest pain treatment

Your healthcare team will also determine which type of heart attack has occurred:

Based on the diagnosis, the medical team will start treatment to restore blood flow through the blocked or partially blocked blood vessels. This may include a procedure or medications.

Both surgery and medication can be highly effective if given early enough, and the method chosen should usually be whichever is likely to open the artery faster.


In the event of a STEMI or NSTEMI, immediate steps must be taken to unblock the artery, get blood flowing through it again as quickly as possible, and prevent damage.

One main treatment is a nonsurgical procedure called coronary angioplasty, also called percutaneous coronary intervention (PCI). A thin tube with a balloon is threaded through a blood vessel to the blocked artery. The balloon is then inflated to push the clot against the artery wall to restore blood flow. A stent may be placed to keep the blood vessel open after the procedure.

Coronary artery bypass grafting may be considered for patients who are not candidates for PCI or who have cardiogenic shock. In this surgery, a healthy vein in your body is harvested and then re-connected in the affected area to bypass the blocked section and restore blood flow to the heart.

With partially blocked blood vessels, patients may also benefit from PCI depending on the level of severity. About 32% to 40% of patients with NSTE acute coronary syndromes will have a PCI done at the hospital.


There are many medications that can be used during and immediately after a heart attack to stop the event and help prevent further damage to the heart.

Thrombolytic Therapy

This approach to treating an acute heart attack involves using medication to break up a blood clot. These powerful drugs, also known as thrombolytics or fibrinolytic agents, are only given in the event of a STEMI. They are given intravenously and nicknamed "clot busters" because they do just that—dissolve blood clots that are in the process of forming. 

Thrombolytic therapy is most likely to be used for STEMI patients if angioplasty can't be performed or isn't a safe option. The best results are obtained if the medication is given as soon as possible after chest pain occurs, usually in less than 12 hours.

A tissue plasminogen activator (tPA) is the type of thrombolytic most often used to break up a blood clot during a heart attack.

The major side effect of thrombolytic therapy is bleeding, making it unsafe for patients at high risk of this complication, such as those who've had recent surgery, have a history of stroke due to brain hemorrhage, or have very high blood pressure.


The most common of these drugs—which reduce the stickiness of platelets, thereby making it difficult for blood clots to form or get bigger—is aspirin.

One-half or one whole uncoated adult aspirin, chewed or crushed, taken as soon as possible when a heart attack (or any acute coronary syndrome event) is suspected can significantly improve outcomes.

Heart attack patients are often treated with dual antiplatelet therapy, meaning that two types of antiplatelet agents are taken to prevent blood clotting. In addition to aspirin, your doctor would prescribe a P2Y12 inhibitor such as clopidogrel, prasugrel, or ticagrelor.

You should discuss with your doctor whether dual antiplatelet therapy is the right treatment for you.


Like antiplatelet drugs, anticoagulants are classified as blood thinners since they slow down your body’s ability to make clots. Given within the first 24 hours of an acute heart attack, a blood thinner helps prevent clotting in your arteries and may lower the risk of long-term mortality.

These drugs include:

  • Heparin
  • Coumadin (warfarin)
  • Eliquis (apixaban)
  • Xarelto (rivaroxaban)

Eliquis, Xarelto, and like drugs are sometimes referred to as novel oral anticoagulants (NOACs).


By impacting the effect of adrenaline, beta-blockers significantly improve the survival of patients with MIs. These drugs are typically recommended the first day after you've had a heart attack.

According to the American Heart Association, the beta-blockers most often prescribed after a heart attack are:

  • Lopressor, Toprol XL (metoprolol)
  • Corgard (nadolol)
  • Inderal (propranolol)
  • Sectral (acebutolol)
  • Tenormin (atenolol)
  • Kerlone (betaxolol)
  • Ziac (bisoprolol/hydrochlorothiazide)
  • Zebeta (Bisoprolol)
  • Betapace (sotalol)

Angiotensin-Converting Enzyme (ACE) Inhibitors

These drugs expand blood vessels and allow blood to flow more easily. ACE inhibitors have been shown to significantly improve the outcome of patients who have significant heart attacks or signs of heart failure, although they also can be beneficial in patients with less severe heart attacks.

ACE inhibitors are usually started during the first 24 hours after a heart attack. Examples include:

  • Lotensin (benazepril)
  • Vasotec (enalapril)
  • Altace (ramipril)


Statins appear to improve survival after a heart attack regardless of cholesterol levels, probably by reducing inflammation or stabilizing coronary artery plaques in some other way.

Most often, statins should be started before a heart attack patient leaves the hospital. Sometimes it's beneficial to begin them even sooner. The primary statins are:

A Word From Verywell

Surviving a heart attack requires ongoing effort after that first critical day. Your doctor will work with you to determine the steps that need to be taken to prevent complications and another event.

Was this page helpful?
Article Sources
Verywell Health uses only high-quality sources, including peer-reviewed studies, to support the facts within our articles. Read our editorial process to learn more about how we fact-check and keep our content accurate, reliable, and trustworthy.
  1. National Heart, Lung, and Blood Institute. Heart Attack

  2. O’Gara P, Kushner F, Ascheim D et al. 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction. Circulation. 2013;127(4). doi:10.1161/cir.0b013e3182742cf6

  3. Smith J, Negrelli J, Manek M, Hawes E, Viera A. Diagnosis and Management of Acute Coronary Syndrome: An Evidence-Based Update. The Journal of the American Board of Family Medicine. 2015;28(2):283-293. doi:10.3122/jabfm.2015.02.140189

  4. Amsterdam E, Wenger N, Brindis R et al. 2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes. Circulation. 2014;130(25). doi:10.1161/cir.0000000000000134

  5. U.S. National Library of Medicine. Thrombolytic drugs for heart attack. MedlinePlus. Updated April 14, 2019. 

  6. Ali MR, Salim Hossain M, Islam MA, et al. Aspect of thrombolytic therapy: a reviewScientificWorldJournal. 2014;2014:586510. doi:10.1155/2014/586510

  7. U.S. National Library of Medicine. Thrombolytic therapy. MedlinePlus. Updated May 16, 2018.

  8. Patel MD, Wu D, Chase MR, et al. Antiplatelet Therapy and Clinical Outcomes Following Myocardial Infarction Among Patients in a U.S. Employer-Based Insurance Database. J Manag Care Spec Pharm. 2017;23(6):684-690. doi:10.18553/jmcp.2017.23.6.684

  9. U.S. National Library of Medicine. Blood Thinners. MedlinePlus.

  10. American Heart Association. Cardiac Medications. Updated January 15, 2020.

  11. Gillette M, Morneau K, Hoang V, Virani S, Jneid H. Antiplatelet Management for Coronary Heart Disease: Advances and Challenges. Curr Atheroscler Rep. 2016;18(6):35. doi:10.1007/s11883-016-0581-6

  12. Han X, Zhang Y, Yin L, et al. Statin in the treatment of patients with myocardial infarction: A meta-analysisMedicine (Baltimore). 2018;97(12):e0167. doi:10.1097/MD.0000000000010167

Additional Reading
Related Articles